Ivosidenib (Tibsovo)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ivosidenib (Tibsovo), covering 2024-10-02 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation [Phase 1, Phase 2]